Advanced search
Publication Cover
Cancer Management and Research Volume 13, 2021 - Issue
Submit an article Journal homepage
72
Views
11
CrossRef citations to date
0
Altmetric
Original Research

LncRNA MAFG-AS1 Suppresses the Maturation of miR-34a to Promote Glioblastoma Cell Proliferation

Hao Zhao1 Department of Neurosurgery, Zibo Central Hospital, Zibo City, Shandong Province, 255036, People’s Republic of China
,
Jun Li1 Department of Neurosurgery, Zibo Central Hospital, Zibo City, Shandong Province, 255036, People’s Republic of China
,
Xin Yan2 Department of Ultrasound, Central Hospital Affiliated to Shandong University, Zibo City, Shandong Province, 255036, People’s Republic of China
&
Xinchao Bian1 Department of Neurosurgery, Zibo Central Hospital, Zibo City, Shandong Province, 255036, People’s Republic of ChinaCorrespondence[email protected]
Pages 3493-3501 | Published online: 22 Apr 2021

References

  • Shabihkhani M, Telesca D, Movassaghi M, et al. Incidence, survival, pathology, and genetics of adult Latino Americans with glioblastoma. J Neurooncol. 2017;132(2):351–358. doi:10.1007/s11060-017-2377-028161760
  • Hibler E. The glioblastoma patient mortality rate and immunosuppression coincidently increase during advanced age. Front Pharmacol. 2019;10:10. doi:10.3389/fphar.2019.0020030733675
  • Brown TJ, Brennan MC, Li M, et al. Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis. JAMA Oncol. 2016;2(11):1460–1469. doi:10.1001/jamaoncol.2016.137327310651
  • Davis ME. Glioblastoma: overview of disease and treatment. Clin J Oncol Nurs. 2016;20(5 Suppl):S2–8. doi:10.1188/16.CJON.S1.2-8
  • Delgado-Lopez PD, Corrales-Garcia EM. Survival in glioblastoma: a review on the impact of treatment modalities. Clin Transl Oncol. 2016;18(11):1062–1071. doi:10.1007/s12094-016-1497-x26960561
  • Batash R, Asna N, Schaffer P, Francis N, Schaffer M. Glioblastoma multiforme, diagnosis and treatment; recent literature review. Curr Med Chem. 2017;24(27):3002–3009. doi:10.2174/092986732466617051612320628521700
  • Juratli TA, Qin N, Cahill DP, Filbin MG. Molecular pathogenesis and therapeutic implications in pediatric high-grade gliomas. Pharmacol Ther. 2018;182:70–79. doi:10.1016/j.pharmthera.2017.08.00628830841
  • Balca-Silva J, Matias D, Carmo AD, Sarmento-Ribeiro AB, Lopes MC, Moura-Neto V. Cellular and molecular mechanisms of glioblastoma malignancy: implications in resistance and therapeutic strategies. Semin Cancer Biol. 2019;58:130–141. doi:10.1016/j.semcancer.2018.09.00730266571
  • Lieberman F. Glioblastoma update: molecular biology, diagnosis, treatment, response assessment, and translational clinical trials. F1000Res. 2017;6:1892. doi:10.12688/f1000research.11493.129263783
  • Touat M, Idbaih A, Sanson M, Ligon KL. Glioblastoma targeted therapy: updated approaches from recent biological insights. Ann Oncol. 2017;28(7):1457–1472. doi:10.1093/annonc/mdx10628863449
  • Ferreira HJ, Esteller M. Non-coding RNAs, epigenetics, and cancer: tying it all together. Cancer Metastasis Rev. 2018;37(1):55–73. doi:10.1007/s10555-017-9715-829374363
  • Arun G, Diermeier SD, Spector DL. Therapeutic targeting of long non-coding RNAs in cancer. Trends Mol Med. 2018;24(3):257–277. doi:10.1016/j.molmed.2018.01.00129449148
  • Cui S, Yang X, Zhang L, Zhao Y, Yan W. LncRNA MAFG-AS1 promotes the progression of colorectal cancer by sponging miR-147b and activation of NDUFA4. Biochem Biophys Res Commun. 2018;506(1):251–258. doi:10.1016/j.bbrc.2018.10.11230348529
  • Sui Y, Lin G, Zheng Y, Huang W. LncRNA MAFG-AS1 boosts the proliferation of lung adenocarcinoma cells via regulating miR-744-5p/MAFG axis. Eur J Pharmacol. 2019;859:172465. doi:10.1016/j.ejphar.2019.17246531211984
  • Slabakova E, Culig Z, Remsik J, Soucek K. Alternative mechanisms of miR-34a regulation in cancer. Cell Death Dis. 2017;8(10):e3100. doi:10.1038/cddis.2017.49529022903
  • Annese T, Tamma R, De Giorgis M, Ribatti D. microRNAs biogenesis, functions and role in tumor angiogenesis. Front Oncol. 2020;10:581007. doi:10.3389/fonc.2020.58100733330058
  • Wang Y, Wang L. miR-34a attenuates glioma cells progression and chemoresistance via targeting PD-L1. Biotechnol Lett. 2017;39(10):1485–1492. doi:10.1007/s10529-017-2397-z28721584
  • Li Q, Wang C, Cai L, et al. miR34a derived from mesenchymal stem cells stimulates senescence in glioma cells by inducing DNA damage. Mol Med Rep. 2019;19(3):1849–1857. doi:10.3892/mmr.2018.980030592284
  • Achkar NP, Cambiagno DA, Manavella PA. miRNA biogenesis: a dynamic pathway. Trends Plant Sci. 2016;21(12):1034–1044. doi:10.1016/j.tplants.2016.09.00327793495

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.